SOPHiA GENETICS officer proposes $6.34K share sale

The notice identifies the shares as restricted stock units acquired from the issuer and lists two earlier sales under Rule 10b5-1.

Available on EDGAR 09/21/2026 - 04:32 PM EDT Accepted by SEC EDGAR 09/21/2026 - 04:31 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

SOPHiA GENETICS SA officer George Cardoza reported a proposed sale of 774 common shares, with an aggregate market value of $6,339.06 and an approximate sale date of September 21, 2026. The notice identifies the shares as restricted stock units acquired from the issuer on September 18, 2026, and lists a Rule 10b5-1 plan adoption date of September 4, 2025. It also reports two 10b5-1 sales during the prior three months: 1,592 shares for gross proceeds of $8,419.45 on July 6, 2026, and 774 shares for $4,163.73 on June 22, 2026.

Key Figures

Proposed sale: 774 common shares Aggregate market value: $6,339.06 Common shares outstanding: 85,127,825 shares +4 more

7 metrics

Proposed sale 774 common shares Approximate sale date: September 21, 2026

Aggregate market value $6,339.06 For the proposed sale of 774 common shares

Common shares outstanding 85,127,825 shares Outstanding-share count listed in the notice

Prior sale 1,592 common shares July 6, 2026

Prior sale gross proceeds $8,419.45 July 6, 2026

Prior sale 774 common shares June 22, 2026

Prior sale gross proceeds $4,163.73 June 22, 2026

Key Terms

Restricted Stock Units, Rule 10b5-1, Aggregate Market Value

3 terms

Restricted Stock Units financial

"Nature of Acquisition Transaction: Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 10b5-1 regulatory

"10b5-1 Sales for George Cardoza"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SOPH shares is George Cardoza proposing to sell?

George Cardoza, an officer of SOPHiA GENETICS SA, reported a proposed sale of 774 common shares, with an aggregate market value of $6,339.06 and an approximate sale date of September 21, 2026.

What prior SOPH sales did George Cardoza report?

The notice lists two 10b5-1 sales during the prior three months: 1,592 shares for gross proceeds of $8,419.45 on July 6, 2026, and 774 shares for $4,163.73 on June 22, 2026.

When was George Cardoza's Rule 10b5-1 plan adopted?

The Rule 10b5-1 plan adoption date listed for George Cardoza is September 4, 2025. The notice gives the proposed sale date as approximately September 21, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001518734
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	GEORGE CARDOZA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	774	6339.06	85127825	09/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/18/2026	Restricted Stock Units	Issuer			774	09/18/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for GEORGE CARDOZA La Piece 12 ch-1180 Rolle V8 00000	Common	07/06/2026	1592	8419.45
10b5-1 Sales for GEORGE CARDOZA La Piece 12 ch-1180 Rolle V8 00000	Common	06/22/2026	774	4163.73

144: Remarks and Signature

Remarks
Date of Notice	09/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/04/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ George Cardoza
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)